for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Beyondspring's Neutropenia Trial Shows Positive Results

June 9 (Reuters) - Beyondspring Inc:

* BEYONDSPRING’S PROTECTIVE-2 (STUDY 106) PHASE 2 TRIAL FOR CHEMOTHERAPY-INDUCED NEUTROPENIA SHOWS POSITIVE RESULTS IN CHEMOTHERAPY OPTIMIZATION WITH POTENTIALLY BETTER CLINICAL OUTCOMES Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up